0001415889-24-017158.txt : 20240617 0001415889-24-017158.hdr.sgml : 20240617 20240617161144 ACCESSION NUMBER: 0001415889-24-017158 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240613 FILED AS OF DATE: 20240617 DATE AS OF CHANGE: 20240617 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jain Rita CENTRAL INDEX KEY: 0001707797 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15006 FILM NUMBER: 241048331 MAIL ADDRESS: STREET 1: C/O AKEBIA THERAPEUTICS, INC. STREET 2: 245 FIRST STREET, SUITE 1100 CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Celldex Therapeutics, Inc. CENTRAL INDEX KEY: 0000744218 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 133191702 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 53 FRONTAGE ROAD STREET 2: SUITE 220 CITY: HAMPTON STATE: NJ ZIP: 08827 BUSINESS PHONE: 908-200-7500 MAIL ADDRESS: STREET 1: 53 FRONTAGE ROAD STREET 2: SUITE 220 CITY: HAMPTON STATE: NJ ZIP: 08827 FORMER COMPANY: FORMER CONFORMED NAME: AVANT IMMUNOTHERAPEUTICS INC DATE OF NAME CHANGE: 19980828 FORMER COMPANY: FORMER CONFORMED NAME: T CELL SCIENCES INC DATE OF NAME CHANGE: 19920703 4 1 form4-06172024_080640.xml X0508 4 2024-06-13 0000744218 Celldex Therapeutics, Inc. CLDX 0001707797 Jain Rita C/O CELLDEX THERAPEUTICS, INC. 53 FRONTAGE ROAD, SUITE 202 HAMPTON NJ 08827 true false false false 0 Non-Qualified Stock Option (right to buy) 36.43 2024-06-13 4 A 0 16500 0 A 2025-06-13 2034-06-13 Common Stock 16500 16500 D Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan. /s/ Sam Martin, attorney-in-fact for Rita I. Jain, M.D. 2024-06-17